SCHEMBL2438732

SCHEMBL2438732

[CH2]C[C@H]1CCCN1C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL147343 1.00
SCHEMBL771996 0.93
SCHEMBL4420100 0.81
SCHEMBL12371218 0.79 CYP1A2 (0.50)
SCHEMBL9996729 0.78 CYP1A2 (0.50)
SCHEMBL294017 0.77
SCHEMBL8325168 0.77
SCHEMBL10206077 0.77
SCHEMBL23844550 0.75 CYP1A2 (0.57)
SCHEMBL1371466 0.75

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-102803247-A Novel fumarate salts of a histamine H3 receptor antagonist SANOFI AVENTIS 2012-11-28 CN claimed
WO-2011109675-A2 PROCESS FOR THE PREPARATION OF 2-(CYCLOHEXYLMETHYL)-N-{2- [(2S)-1-METHYLPYRROLIDIN-2-YL]ETHYL}-1, 2, 3, 4- TETRAHYDROISOQUINOLINE-7-SULFONAMIDE SANOFI (FR) 2011-09-09 WO claimed
CN-102803247-A Novel fumarate salts of a histamine H3 receptor antagonist SANOFI AVENTIS 2012-11-28 CN disclosed
WO-2011109675-A2 PROCESS FOR THE PREPARATION OF 2-(CYCLOHEXYLMETHYL)-N-{2- [(2S)-1-METHYLPYRROLIDIN-2-YL]ETHYL}-1, 2, 3, 4- TETRAHYDROISOQUINOLINE-7-SULFONAMIDE SANOFI (FR) 2011-09-09 WO disclosed